Related by context. All words. (Click for frequent words.) 76 Elesclomol 75 oral dual endothelin 74 sorafenib tablets 74 Methylnaltrexone 74 Talabostat 74 LymphoStat B belimumab 74 sodium glucose cotransporter 74 oral dihydropyrimidine dehydrogenase DPD 73 Romiplostim 73 MAGE A3 ASCI 73 TNF Tumor Necrosis Factor 73 Sapacitabine 73 IMiDs ® 73 dasatinib Sprycel ® 72 BLyS specific 72 Ofatumumab 72 Traficet EN 72 BENLYSTA belimumab 72 PEGylated Fab fragment 72 MERREM 72 Dapagliflozin 72 Crofelemer budesonide foam 72 receptor inhibiting monoclonal 72 humanized therapeutic 71 Pegloticase 71 Meets Primary Endpoint 71 Silodosin 71 formerly LymphoStat B 71 humanized interleukin 6 71 AAG geldanamycin analog 71 small molecule thrombopoietin 71 PEGylated anti 71 CYT# potent vascular disrupting 71 YONDELIS 71 Tocilizumab 71 methylnaltrexone bromide 71 HYVISC ® treatment 71 Adalimumab 71 Gamunex C 70 Liprotamase 70 Humanized Anti 70 developing Bicifadine serotonin 70 Sodium oxybate 70 Epratuzumab 70 chimeric monoclonal antibody 70 nilotinib Tasigna ® 70 oral prodrug 70 INSPIRE Trial Phase III 70 Rigel R# 70 VEGFR2 inhibitor 70 GW# [003] 70 Ustekinumab 70 Zorbtive TM 70 ADP receptor antagonist 70 Panzem R 70 pseudobulbar affect PBA 70 Dementia Related Psychosis 70 topical gel formulation 70 memantine HCl 70 class mGluR5 inhibitor 70 immunotherapeutic agent 70 Lubiprostone 70 SPL# Gel vaginal microbicide 70 orally administered inhibitor 70 Aflibercept 70 Blinatumomab 70 CYP#A# isoenzyme 70 Eculizumab 70 proteasome inhibitor 70 imatinib Gleevec ® 70 erlotinib Tarceva ® 70 Tezampanel 70 Linaclotide 70 ZOLINZA 70 phase III isavuconazole 70 Hsp# Inhibitor 70 hypereosinophilic syndrome 70 Aliskiren 70 RANK Ligand inhibitor 69 CYP#A# CYP#D# 69 Temsirolimus 69 investigational oral inhibitor 69 protein tyrosine phosphatase 1B 69 Oracea TM 69 investigational pharmacologically unique 69 Certolizumab pegol 69 IMiDs ® compound 69 Tanespimycin 69 inflammatory PDE 69 Eltrombopag 69 R Saizen R 69 peripherally acting 69 mild vasodilator 69 Saxagliptin 69 Maribavir 69 Vandetanib 69 NS5b 69 non nucleoside inhibitor 69 IMiDs R 69 vitreoretinal disorders 69 oncolytic virus therapies 69 R sorafenib tablets 69 selective modulator 69 humanised monoclonal antibody 69 Mg Uk 69 vapreotide acetate 69 multi kinase inhibitor 69 Horizant ™ 69 brand ciclesonide HFA 69 Elvitegravir 69 RhuDex R 69 dihydrochloride Tablets 69 Glufosfamide 69 autologous cellular immunotherapy 69 administered concomitantly 69 Plecanatide 69 MKC# MKC# PP 69 Golimumab 69 sunitinib Sutent ® 69 Budesonide foam crofelemer 69 Cethromycin 69 personalized cellular immunotherapy 69 Tibotec Therapeutics division 69 Vidofludimus 69 CCR5 receptor antagonist 69 delta gamma agonist 69 albiglutide 69 Archexin 69 Aztreonam lysine 69 Personalized Immunotherapy 69 Tesetaxel 69 receptor tyrosine kinase inhibitor 69 Sudhir Agrawal D.Phil 69 HCV NS5B polymerase 69 Otelixizumab 69 Plicera 69 Teriflunomide 69 generation Hsp# inhibitor 69 pralatrexate injection folate analogue 69 rilonacept 69 ALVESCO R 69 Kuvan sapropterin dihydrochloride 69 Mg Usa 69 small molecule Hedgehog 69 investigational humanized monoclonal antibody 69 HQK 69 CRM# Protein 69 monoclonal antibody IgG1 Mab 68 Mipomersen 68 intravesical infusion therapy 68 PRN FDA Approves 68 Pruvel TM 68 Tasimelteon 68 label Lipofen R 68 Novel Antibiotic 68 virus HCV protease inhibitor 68 Initiates Enrollment 68 diarrhea predominant irritable 68 Dasatinib 68 R memantine HCl 68 Dalbavancin 68 Granted Orphan Drug 68 MKC# MT 68 PNP inhibitor 68 D aspartate NMDA receptor 68 kidney urologic 68 BEMA ® 68 Aviptadil 68 evaluating tivozanib 68 erlotinib Tarceva R 68 CCR9 antagonist 68 Voreloxin 68 UCB www.ucb group.com 68 Critical Therapeutics Zyflo 68 Etanercept 68 5 HT3 antagonist 68 approved incretin mimetic 68 includes AstraZeneca Accolate 68 Clevudine 68 Carfilzomib 68 ACTEMRA TM 68 * olmesartan medoxomil 68 SWX BSLN 68 vaccine RiVax TM 68 nanofiltered plasma derived 68 Phase 2a Clinical Trial 68 RhuDex ® 68 Peginterferon alfa 2b 68 Zolinza 68 MSCRAMM ® 68 Complicated Skin 68 delivers fluocinolone acetonide FA 68 TRANSDUR ® 68 GRNOPC1 contains 68 Inhalation Aerosol 68 BENLYSTA TM 68 Emtriva Viread 68 IAP inhibitor 68 potent topoisomerase II 68 Xyrem ® 68 Piperacillin 68 triggers apoptosis programmed 68 mertansine 68 Vimpat R 68 5 HT6 receptor 68 novel VDA molecule 68 Desvenlafaxine 68 Vaccine Adjuvant 68 ELADUR ™ 68 reduce serum phosphate 68 iloprost synthetic compound 68 metaglidasen 68 product BioThrax ® 68 available dual endothelin 68 tenofovir disoproxil fumarate Viread 68 nucleoside analog 68 oral ghrelin agonist 68 baminercept 68 Besivance 68 Systemic lupus erythematosus SLE 68 TACI Ig 68 decompensated liver disease 68 echinocandin 68 humanized monoclonal antibody 68 BCG refractory carcinoma 68 MTP inhibitor 68 BYETTA ® 68 NOTE POSIDUR ™ 68 Ridaforolimus 68 novel topoisomerase 68 delta opioid receptor 68 EPIVIR 68 Provectus Pharmaceuticals specializes 68 HuMax CD4 68 Aeolus Pharmaceuticals Announces 68 HCV Protease Inhibitor 68 CCX# 68 LymphoStat B TM 68 Vicriviroc 68 R lenalidomide 68 incretin mimetic 68 included exfoliative dermatitis 68 Romidepsin 68 DORIBAX 68 Icatibant 68 non peptidic protease 68 Phase 2b Clinical Trial 68 agonistic human 68 Empatic ™ 68 OMP #R# 68 Copegus R 68 highly purified pasteurized 68 Boceprevir 68 GSK# [001] 68 Daclizumab 68 Firdapse TM amifampridine phosphate 68 selective serotonin 2C receptor 68 certain protein tyrosine 67 Completes Patient Enrollment 67 Bavituximab 67 leading oral taxane 67 PEGINTRON TM 67 XL# anticancer compounds 67 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 67 acyclovir Lauriad R 67 Aganocide 67 Vitrasert R 67 Curis collaborator Genentech 67 Bosutinib 67 hyperphenylalaninemia HPA due 67 Copegus ® 67 Ocrelizumab 67 intranasal formulation 67 Bafetinib 67 Campath ® 67 HuMax EGFr 67 Serostim ® 67 Nitazoxanide 67 Brentuximab vedotin 67 adalimumab Humira 67 dimebon latrepirdine 67 STELARA TM 67 Custirsen 67 Oral Fingolimod 67 Bucindolol 67 Second Pivotal Phase 67 PROVENGE sipuleucel T 67 Bortezomib 67 refractory cutaneous T 67 M# rationally 67 Mylan Receives Approval 67 MEK Inhibitor 67 IMPDH inhibitor 67 IgG1 monoclonal antibody 67 include Alferon N 67 PDE4 inhibitor 67 Elotuzumab 67 constipation OIC 67 HuCAL PLATINUM ® CysDisplay 67 mGluR5 NAM 67 Virulizin ® 67 DDP# 67 antibody MAb 67 post herpetic neuralgia PHN 67 peptidic compound 67 selective A2A adenosine receptor 67 TRIOLEX HE# APOPTONE HE# 67 nucleotide analogue 67 vinca alkaloid 67 beta 1a 67 JAK2 Inhibitor 67 orally inhaled migraine 67 orphan medicinal product 67 norepinephrine reuptake inhibitor 67 therapeutically inactive prodrug 67 factor TNF receptor 67 visilizumab 67 Elagolix 67 R MSCRAMM 67 Laquinimod 67 R roscovitine 67 Ranolazine 67 opioid narcotic 67 use transdermal sumatriptan 67 NEBIDO VANTAS SUPPRELIN LA 67 investigational monoclonal antibody 67 Melphalan 67 relapsed MM 67 Aflibercept VEGF Trap 67 Zalypsis 67 Obatoclax 67 Biogen Genentech 67 Cutaneous T 67 CTA# Injection 67 novel synthetic PEGylated 67 6R BH4 67 Arranon 67 topically applied SEPA 67 KNS # 67 RoACTEMRA 67 infectious diseases autoimmune diseases 67 cMET 67 mGluR2 positive 67 LymphoStat B 67 Ovitrelle R Serostim 67 Actemra tocilizumab 67 EOquin TM phase 67 Febuxostat 67 markets COLAZAL 67 First Patient Dosed 67 oral proteasome inhibitor 67 Xeloda ® 67 peptibody 67 CCX# B 67 NS5B polymerase 67 R metformin Concor 67 Pirfenidone 67 Randomized Double blind 67 CDK cyclin dependent 67 IAP inhibitors 67 TRANSDUR ™ 67 Vildagliptin 67 Nexavar ® 67 novel oral anticoagulant 67 Phase IIb Trial 67 SPRYCEL ® 67 Coadministration 67 Pemetrexed 67 Omacetaxine mepesuccinate 67 HuMax TAC 67 unique alkylating agent 67 BRIM2 67 Investigational Treatment 67 efalizumab 67 acute humoral rejection 67 Gemzar ® 67 Fludara ® 67 Tasigna nilotinib 67 markets Gelclair R 67 human IgG1 monoclonal 67 HCD# [002] 67 Investigational Compound 67 Tofacitinib 66 Receives Fast Track 66 metformin HCl 66 5 HT2A inverse 66 Oral NKTR 66 Certolizumab 66 Ambrisentan 66 hyaluronidase enzyme 66 recombinant PSMA vaccine 66 dopamine receptor agonist 66 Prodarsan R 66 castrate resistant prostate cancer 66 pramlintide acetate injection 66 somatostatin analog 66 sertraline Zoloft 66 docetaxel Taxotere R 66 dose intramuscular 66 trastuzumab Herceptin R 66 Degarelix 66 Anidulafungin 66 diabetic neuropathic pain 66 By JENNIFER LEARN 66 Certican 66 specific CCR9 antagonist 66 cutaneous T 66 angiogenesis inhibitor 66 Epothilones 66 CERVARIX 66 Arimoclomol 66 Kuvan R 66 either acutely decompensated 66 Unit Dose Budesonide 66 treat lupus renal 66 refractory chronic lymphocytic 66 severe gastroparesis 66 Phase Ib IIa 66 Pertuzumab 66 Teplizumab 66 SABER ™ 66 FOLOTYN ® 66 Cetrorelix 66 B lymphocyte stimulator 66 thalidomide Thalomid 66 Interferon beta 1b 66 5 lipoxygenase activating 66 alefacept 66 Prochymal TM 66 plasma kallikrein inhibitor 66 LY# [002] 66 Eraxis 66 BENLYSTA ® 66 Sciences ABthrax Albuferon 66 IMiDs 66 Raptiva R 66 Pagoclone 66 Pafuramidine 66 Alinia 66 sapacitabine CYC# 66 Late Breaker 66 CYP#A# substrate 66 ALVESCO ® 66 myelofibrosis polycythemia vera 66 KRN# 66 liposomal formulation 66 Zarnestra 66 TEMODAL 66 product candidate Lpathomab 66 CIMZIA TM 66 tocilizumab 66 folate analogue metabolic 66 alpha 2b 66 PDE# 66 directed radiotherapeutic antibody 66 candidate deforolimus 66 Tarceva TM 66 etanercept Enbrel 66 Muraglitazar 66 5 lipoxygenase inhibitor 66 antiplatelet compound 66 BENICAR HCT 66 Hormone Refractory Prostate Cancer 66 pathophysiological effects 66 Paliperidone Palmitate 66 Peginterferon 66 xanthine oxidase inhibitor 66 recurrent glioblastoma multiforme 66 DEB# 66 Nasdaq AEGR 66 Hycamtin 66 RhuDex 66 product Fentanyl TAIFUN 66 R rilonacept Injection 66 melanocortin receptor agonists 66 LHRH antagonists 66 Phase 2b Trial 66 octreotide acetate 66 nasal calcitonin product 66 receptor inhibitor 66 polymerase inhibitor 66 docetaxel Taxotere ® 66 Trabectedin 66 See CLINICAL PHARMACOLOGY 66 Tetanus Toxoid Reduced Diphtheria 66 Relapsed Refractory 66 oversulfated version 66 biologic DMARD 66 Initiates Phase III 66 FDA APPROVES 66 novel nucleoside analog 66 novel immunomodulatory 66 ketolide antibiotic 66 Fast Track designations 66 systemic juvenile idiopathic 66 Ixempra 66 CEL SCI Phase III 66 serotonin norepinephrine reuptake inhibitors 66 Abiraterone acetate 66 Relapsed Multiple Myeloma 66 dasatinib Sprycel 66 Ophena TM 66 TURNING INSIGHTS INTO HOPE 66 rasagiline tablets 66 Ostarine ™ 66 IgG1 antibody 66 Acute Bacterial Sinusitis ABS 66 relapsed leukemia 66 itraconazole Sporanox 66 Crizotinib PF # 66 TYZEKA 66 infliximab monotherapy 66 IMA# 66 Risperidone Oral Solution 66 Inhalation Solution 66 myelodysplastic myeloproliferative diseases 66 toenail onychomycosis 66 PKC# 66 coronary stent merged 66 Suppository Hydrocortisone Acetate Rectal 66 lead heptagonist compound 66 specific lectin receptors 66 C1 INH deficiency 66 SNT-MC#/idebenone 66 DG# compounds targeting 66 CCR5 mAb 66 recombinant subunit vaccine 66 candidate XP# 66 Combination REOLYSIN R 66 Omacetaxine 66 candidate custirsen 66 investigational biologic 66 inhaled formulation 66 HGS ETR1 mapatumumab 66 Zoraxel 66 mTOR inhibitor 66 alfa 2a 66 Albuferon TM 66 Decitabine 66 Safinamide 66 Atripla combines 66 cathepsin K inhibitor 66 dihydroergotamine 66 Torisel 66 MT#/MEDI-# 66 immunomodulator 66 Ceftaroline 66 Ribavirin causes 66 Actonel risedronate 66 Celebrex celecoxib 66 YOUR LOCAL ANIMAL SHELTER 66 aripiprazole Abilify 66 camptothecin CPT 66 pan histone deacetylase 66 Initiate Phase III 66 injectable investigational 66 3TC lamivudine 66 Simulect 66 Dose Escalation 66 Submits Biologics License Application 66 Interferon alfa 2b 66 Nutra Pharma wholly owned 66 RAS MAPK pathway 66 Cancidas 66 gastrointestinal stromal tumors GIST 66 Pegasys ® 66 chronic eosinophilic leukemia 66 forodesine 66 thiazolides 66 Toctino ® alitretinoin 66 Fingolimod 66 mTOR mammalian target 66 specifically hypoactive sexual 66 dyskinesia PD LID 66 Alemtuzumab 66 rivastigmine Exelon 65 Rilonacept 65 Perifosine KRX 65 GATTEX ® 65 BRILINTA 65 TYKERB 65 alpha folate receptor 65 platform HDL Mimetic 65 thetreatment 65 human Chorionic Gonadotropin 65 CD4 monoclonal antibody 65 anticoagulant reversing agent 65 MKC# 65 Focetria 65 PD LID 65 pentadentate logo R 65 PRTX 65 dopamine partial agonist 65 Wafer polifeprosan 65 Solzira TM 65 oral nucleoside analogue 65 GTC recombinant human 65 Ramelteon 65 Albuferon albinterferon alfa 2b 65 Carbidopa Levodopa 65 AVASTIN 65 Advanced Renal Cell 65 riociguat 65 HuLuc# 65 Altera Nebulizer System 65 TBC# 65 modified glutathione analog 65 Tolvaptan 65 Maraviroc 65 Nanobody 65 Adjuvant Treatment 65 reuptake inhibitor 65 Enzastaurin 65 commercialize apixaban 65 GSK '# 65 Treatment Experienced 65 Adecatumumab 65 metformin sulfonylureas 65 posaconazole 65 Orally administered 65 OAB overactive bladder 65 Pooled Analysis 65 blinded randomized placebo controlled 65 ZALBIN 65 somatostatin analogue 65 TNF alpha selectively neutralizing 65 Aztreonam Lysine 65 5 HT4 65 lead Aganocide compound 65 Pivotal Phase III 65 Clofarabine 65 Noxafil 65 Ticagrelor 65 Fibrillex TM 65 Files IND 65 containing granisetron 65 Eszopiclone 65 Zenvia ™ 65 FDA Accepts 65 rheumatoid arthritis RA psoriatic 65 Alogliptin 65 HMG CoA reductase inhibitors 65 Vidaza azacitidine 65 JANUVIA 65 Randomized Phase 65 INVEGA ® 65 insulin sensitizers 65 Phase III Clinical Trial 65 administered intranasally 65 Janus kinase 65 non porcine pancreatic 65 metastatic colorectal 65 Lenocta TM sodium stibogluconate 65 Lambert Eaton Myasthenic 65 eosinophilic asthma 65 Navelbine ® 65 reversible inhibitors 65 Empatic TM 65 atypical antipsychotic medication 65 Initiates Phase II 65 DexaSite 65 Panflu TM Sinovac 65 novel orally inhaled 65 Genasense ® 65 thymalfasin 65 purified inactivated vaccine 65 Deforolimus 65 SAR# [002] 65 anti VEGF aptamer 65 AN# topical anti 65 PEGylated interferon beta 1a 65 Staphylococcus aureus Immune Globulin 65 Lenocta 65 4SC AG ISIN DE# 65 INCB# [001] 65 de novo kidney transplant 65 CIMZIA ™ 65 4 PDE4 enzyme 65 dihydrofolate reductase 65 Refractory Hodgkin Lymphoma 65 Antitumor Activity 65 clinical trials Archexin 65 RhuDex TM 65 Loceryl ® 65 levocetirizine 65 Saquinavir 65 interferon gamma 1b 65 selective phosphodiesterase 65 mGluR5 negative 65 allosteric modulator PAM 65 KERYX BIOPHARMACEUTICALS 65 Civacir TM Hepatitis C 65 HCV polymerase inhibitors 65 pediatric Crohn disease 65 GTC recombinant form 65 refractory gout 65 Adjunctive Therapy 65 Eniluracil 65 Pathway Inhibitor 65 Ixabepilone 65 leukotriene receptor antagonist 65 receiving immunosuppressive therapy 65 Naive Patients 65 Intravenous Human 65 NicVAX TM 65 AEG# 65 liver resection surgeries 65 Through Glycoscience 65 Seliciclib 65 stage antibody MT# 65 CERVARIX R 65 recurrent metastatic ovarian cancer 65 LUVENIQ 65 Soluble CD# 65 GATTEX TM 65 CysDisplay R 65 selective androgen receptor modulator 65 Tekamlo 65 Zoraxel TM 65 IBS C 65 NU# direct 65 Duloxetine 65 Cariprazine 65 WX UK1 65 bone marrow reticulin deposition 65 Tyrima 65 immunomodulating 65 RNAi Therapeutic 65 highly selective inhibitor 65 tetracycline antibiotic 65 5 HT2A serotonin 65 LAB CGRP 65 APTIVUS ritonavir 65 aflibercept VEGF Trap 65 investigational oral 65 markets HP Acthar 65 INTEGRILIN R 65 Valopicitabine 65 Clolar ® 65 Denufosol 65 inhalation powder 65 R bisoprolol Euthyrox 65 pharmacogenomic translational research 65 CINQUIL 65 Recombinant interferon alpha 65 Levofloxacin 65 Zeldox 65 Namenda ® 65 FOLFOX6 chemotherapy regimen 65 investigational immunotherapy 65 Ataluren 65 Sebivo 65 Bazedoxifene 65 combines bupropion 65 systemic RNAi therapeutic 65 Dabigatran etexilate 65 ORENCIA R 65 lamotrigine Lamictal 65 CYT# QbG# 65 Soft Tissue Sarcoma 65 Fast Track Status 65 colesevelam HCl 65 HIV treatments Reyataz 65 endothelin receptor antagonists 65 Zileuton 65 hepatoprotective agent 65 Chronic HCV 65 active AKT inhibitor 65 SIX BSLN 65 FUSILEV ® 65 Angiocept 65 angiotensin II receptor blocker 65 acetonide FA 65 Roflumilast 65 primary Restless Legs 65 basiliximab 65 Heterozygous Familial Hypercholesterolemia 65 Hedgehog Pathway Inhibitor 65 Firdapse ™ amifampridine phosphate 65 Interferon alpha 65 solid tumors ZYBRESTAT 65 FRDA 65 ALN TTR 65 COPEGUS R 65 PI3K/Akt pathway inhibitor 65 novel histone deacetylase 65 NOXAFIL 65 XIAFLEX ™ 65 armodafinil Tablets C 65 Olaparib 65 Known generically 65 nilotinib Tasigna 65 CCR5 antagonist 65 neuraminidase inhibitor 65 PORxin TM platforms 65 Atacicept 65 generation antisense inhibitor 65 Annamycin 65 EGFr humanized monoclonal antibody 65 R#/MEM # 65 oropharyngeal candidiasis OPC 65 TRISCUIT crackers 65 lintuzumab SGN 65 Amgen Neulasta R 65 Schering Plough Remicade 65 Bystolic nebivolol 65 Restoraderm R 65 DepoCyt ® Abelcet ® 65 Bevacizumab 65 aerosolized AAT 65 oral rivaroxaban 65 Syndrome LEMS 65 reslizumab 65 vascular occlusive diseases 65 IMPACS TM 65 naloxol derivative 65 tizanidine hydrochloride short 65 dextromethorphan quinidine 65 Multiple Ascending Dose 65 Cethrin R 65 Ziprasidone 65 Announces Tentative Approval 65 Darunavir 65 Cannabinor 65 anti angiogenic agent 65 Vertex hepatitis C 65 BiTE R 65 HCV RNA polymerase 65 ISENTRESS raltegravir 65 demethylation agents 65 Lenalidomide 65 factor Xa 65 HuMax HepC 65 pan HDAC inhibitor 65 prostate secretory 65 Trobalt 65 pan BCR ABL 65 DNA methyltransferase inhibitors 65 Kamada AAT 65 rheumatoid arthritis psoriatic arthritis 65 Single Dose 65 rheumatoid arthritis juvenile idiopathic 65 thiazolidinedione TZD 65 oral salmon calcitonin 65 CTAP# Capsules 65 candidate SMaRT Replacement 65 orally bioavailable 65 Excellarate TM 65 oropharyngeal candidiasis 65 Arikace 65 azelastine hydrochloride 65 BARACLUDE ® 65 investigational protease inhibitor 65 methylnaltrexone 65 pregabalin Lyrica 65 Catapres TTS 65 alvespimycin 65 anti secretory 65 Trodusquemine MSI 65 Chronic Hepatitis C 64 chronic idiopathic thrombocytopenic purpura 64 quetiapine Seroquel 64 BCR ABL inhibitor 64 FDA Orphan Drug 64 nucleoside analogue 64 active ankylosing spondylitis 64 Anti Tumor 64 HCl PEPCID ® famotidine 64 canakinumab 64 familial amyloidotic polyneuropathy FAP 64 tigecycline 64 rilonacept Injection 64 Arzerra TM 64 zolpidem tartrate sublingual tablet 64 Anti TNF 64 Receives Orphan Drug 64 desire disorder HSDD 64 acyclovir valacyclovir 64 Epivir 64 PMX # PolyMedix 64 Cardium Therapeutics TM 64 hormone agonist 64 Sprycel dasatinib 64 interferon beta 1a infertility 64 Dacetuzumab 64 vaginal candidiasis 64 OMNARIS HFA 64 targeted anticancer biopharmaceuticals 64 fluoroquinolone class 64 B Anflu R 64 including eniluracil ADH 64 BAY #-# 64 autologous cellular immunotherapies 64 Ceflatonin 64 investigational pan BCR 64 ofatumumab HuMax CD# 64 Amrubicin 64 Inhalation Powder 64 Nilotinib 64 ospemifene 64 infectious diseases autoimmune 64 MEVACOR 64 Smac mimetics 64 serotonin norepinephrine reuptake inhibitor 64 Recombinant Human 64 arthritis PsA 64 Syncria R 64 Palifosfamide 64 diabetic gastroparesis 64 biologic therapy 64 delivery polymer matrix 64 Initiate Phase 64 pegylated interferon alfa 2a 64 lenalidomide Revlimid R 64 TYGACIL 64 bendamustine HCl 64 Thiazolidinediones 64 Antitumor 64 Rebif ® 64 Aurora Kinase 64 rheumatoid arthritis osteoarthritis ankylosing 64 Double Blind Placebo 64 allosteric modulator NAM 64 PLX STROKE targeting 64 sorafenib Nexavar 64 Glatiramer Acetate 64 Transdermal Patch 64 2 methoxyestradiol 64 statin HMG CoA reductase 64 CEQ# 64 selective androgen receptor modulators 64 direct renin inhibitor 64 First Patient Enrolled 64 ELND# 64 ganetespib 64 Irinotecan 64 radezolid 64 EDEMA3 64 broad spectrum cephalosporin 64 ACTIQ ® 64 esomeprazole Nexium 64 metastatic hormone refractory 64 bucindolol hydrochloride 64 selective estrogen receptor 64 neuropathic pain metabolic diseases 64 Europe entitled MINDSET 64 sapropterin dihydrochloride 64 HepeX B TM 64 cosmetic cosmeceutical products 64 azoles 64 Orphan Status 64 Kit CD# positive 64 INCB# [003] 64 Velcade bortezomib 64 ACUROX ® 64 Phase III Pivotal 64 Warfarin Coumadin 64 metformin sulfonylurea 64 Pharmacokinetics PK 64 Ceflatonin R 64 Toremifene 64 Namenda Memantine HCl 64 Bremelanotide 64 midstage clinical 64 PSMA ADC 64 Pimavanserin 64 Preclinical Data 64 selective adhesion molecule 64 Long Term Efficacy 64 Medarex logo 64 Demonstrates Efficacy 64 Previously Treated 64 sapropterin dihydrochloride Tablets 64 oral ridaforolimus 64 Raltegravir 64 Cloretazine VNP#M 64 NUVIGIL ® 64 eltrombopag 64 selective kinase inhibitor 64 administered subcutaneously 64 non thiazolidinedione TZD 64 adult chronic ITP 64 Submits NDA 64 anti androgen 64 biologic antibody 64 Rivaroxaban 64 Nasal Powder 64 MabCampath 64 Letairis ambrisentan 64 evaluating T DM1 64 Lymphocytic 64 Hemispherx flagship products 64 Pralatrexate 64 Forodesine HCl 64 Gleevec resistant 64 Bezielle 64 Jevtana 64 molecular chaperone regulator 64 Ecallantide